AGL 37.89 Decreased By ▼ -1.69 (-4.27%)
AIRLINK 126.00 Decreased By ▼ -5.22 (-3.98%)
BOP 6.83 Increased By ▲ 0.02 (0.29%)
CNERGY 4.45 Decreased By ▼ -0.26 (-5.52%)
DCL 7.89 Decreased By ▼ -0.55 (-6.52%)
DFML 37.32 Decreased By ▼ -4.15 (-10.01%)
DGKC 77.50 Decreased By ▼ -4.59 (-5.59%)
FCCL 30.60 Decreased By ▼ -2.50 (-7.55%)
FFBL 69.02 Decreased By ▼ -3.85 (-5.28%)
FFL 11.89 Decreased By ▼ -0.37 (-3.02%)
HUBC 105.50 Decreased By ▼ -5.24 (-4.73%)
HUMNL 13.50 Decreased By ▼ -1.01 (-6.96%)
KEL 4.67 Decreased By ▼ -0.52 (-10.02%)
KOSM 7.28 Decreased By ▼ -0.33 (-4.34%)
MLCF 36.60 Decreased By ▼ -2.30 (-5.91%)
NBP 65.30 Increased By ▲ 1.29 (2.02%)
OGDC 181.00 Decreased By ▼ -11.82 (-6.13%)
PAEL 24.58 Decreased By ▼ -1.10 (-4.28%)
PIBTL 7.15 Decreased By ▼ -0.19 (-2.59%)
PPL 144.00 Decreased By ▼ -10.07 (-6.54%)
PRL 24.40 Decreased By ▼ -1.43 (-5.54%)
PTC 16.40 Decreased By ▼ -1.41 (-7.92%)
SEARL 78.61 Decreased By ▼ -3.69 (-4.48%)
TELE 7.20 Decreased By ▼ -0.56 (-7.22%)
TOMCL 32.01 Decreased By ▼ -1.45 (-4.33%)
TPLP 8.15 Decreased By ▼ -0.34 (-4%)
TREET 16.10 Decreased By ▼ -0.52 (-3.13%)
TRG 54.89 Decreased By ▼ -2.51 (-4.37%)
UNITY 27.50 Decreased By ▼ -0.01 (-0.04%)
WTL 1.29 Decreased By ▼ -0.08 (-5.84%)
BR100 10,116 Decreased By -388.7 (-3.7%)
BR30 29,567 Decreased By -1659.1 (-5.31%)
KSE100 94,574 Decreased By -3505.6 (-3.57%)
KSE30 29,445 Decreased By -1113.9 (-3.65%)

Asthma patients could lead a normal life, completely free from symptoms of the disease, and 'well-controlled and total controlled asthma' is maintainable after it is achieved.
The results of a year-long international study - GOAL (Gaining Optimal Asthma Control) challenge the way patients currently approach or manage asthma, says Professor Eric D. Bateman, professor of respiratory medicine at the University of Cape Town, South Africa.
Delivering his lecture on "aiming for total control in asthma management" at a symposium "From Goal to Asthma Control" at a local hotel here on Saturday, he said that attention must be drawn towards the need for better asthma management on part of doctors and patients alike.
Eric Bateman, who is also one of the leading investigators of the Goal study, maintained that the Goal findings are of paramount importance and serve as a major breakthrough in asthma management. The study establishes the efficacy of a new combination therapy for asthma and illustrates that the globally recognised treatment guidelines for asthma control are 100-percent achievable and a vast majority of asthma patients, currently living with the burden of the disease, can live an almost asthma-free life. The way asthma patients currently treat their disease fall far short of the standard definition of control as defined by the Goal study or the international guidelines for asthma control, he pointed out.

Copyright Business Recorder, 2006

Comments

Comments are closed.